This unit is specialized in delivering the most advanced medical treatment for cancer types patients, providing HCP’s with cutting-edge cancer treatment products (chemotherapy, immunotherapy, targeted therapy, and stem-cell transplant supportive therapy).
Addressing the continuous development of treatment in oncology with the most innovative medicine through our top global specialized pharmaceutical companies including:
- TAXOTERE® (docetaxel)
- ZALTRAP® (ziv-aflibercept)
- LIBTAYO® (cemiplimab-rwlc)
- MOZOBIL® (plerixafor)
- JEVTANA® (cabazitaxel)
- ELOXATIN® (oxaliplatin)
- FLUDARA® (fludarabine)
- FASTURTEC® (rasburicase)
- SARCLISA® (isatuximab)
- COPIKTRA® (duvelisib)
- Alimta® (pemetrexed)
- Cyramza® (ramucirumab)
- Verzenio (abemaciclib)
- Zepzelca (lurbinectedin)
- Cosmegen® (Dactinomycin)
- LEDAGA (chlormethine gel)
- Fluta Cell (Flutamide)
- Oncovin (Vincristine)
- Bortada (bortezomib)
- Xaluprine® (Mercaptopurine)
- Jylamvo (Methotrexate)
